Leukocyte Immunoglobulin-Like Receptor A3 (LILRA3): A Novel Marker for Lymphoma Development among Patients with Young Onset Sjogren's Syndrome.
Evangelia ArgyriouAdrianos NezosPetros RoussosVenetsanopoulou I AlikiMichael VoulgarelisKyriaki BokiAthanasios G TzioufasHaralampos M MoutsopoulosClio P MavraganiPublished in: Journal of clinical medicine (2021)
The functional LILRA3 gene variant increases susceptibility to SS-related lymphoma development in patients with a disease onset of <40 years old, implying that genetically determined deranged immune responses in younger SS individuals could underly their pronounced risk for lymphoma development.